NeoPharm CO., LTD. (KOSDAQ:092730)

NeoPharm CO., LTD. Revenue

In the year 2025, NeoPharm CO., LTD. had annual revenue of 132.18B KRW with 11.07% growth. NeoPharm CO., LTD. had revenue of 36.40B in the quarter ending December 31, 2025, with 6.97% growth.

• Revenue: 132.18B
• Revenue Growth: +11.07%
• P/S Ratio: 2.03
• Revenue / Employee: 742.61M
• Employees: 178
• Market Cap: 267.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	132.18B	13.17B	11.07%
Dec 31, 2024	119.01B	21.91B	22.56%
Dec 31, 2023	97.10B	12.07B	14.20%
Dec 31, 2022	85.03B	-2.90B	-3.30%
Dec 31, 2021	87.93B	6.31B	7.72%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error